Human breast cancer cells: parental v.s lapatinib-resistant clone

ABSTRACT: Transcriptional profiling of human HER2-positive BT474 breast cancer cells comparing control untreated cancer cells with lapatinib-resistant clone established by chronic treatment with lapatinib Two-condition experiment, parental cells vs. lapatinib-resistant (LR) clone.

ORGANISM(S): Homo sapiens

SUBMITTER: Huang Wei-Chien 

PROVIDER: S-ECPF-GEOD-51889 | biostudies-other |

REPOSITORIES: biostudies-other